January 02, 2026 09:33 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
New Year horror in Switzerland: Dozens feared dead in Crans-Montana bar explosion | Tobacco stocks crushed as govt slaps fresh excise duty from Feb 1 | Vodafone Idea shares explode 10% after surprise settlement and govt relief boost | No third party involved: India govt sources refute China’s Operation Sindoor ceasefire claim | Amit Shah blasts TMC over border fencing; Mamata fires back on Pahalgam and Delhi blast | 'A profound loss for Bangladesh politics': Sheikh Hasina mourns Khaleda Zia’s death | PM Modi mourns Khaleda Zia’s death, hails her role in India-Bangladesh ties | Bangladesh’s first female Prime Minister Khaleda Zia passes away at 80 | India rejects Pakistan’s Christmas vandalism remarks, cites its ‘abysmal’ minority record | Minority under fire: Hindu houses torched in Bangladesh village
Astra-Zeneca
Pixabay

Bangladesh seeks to produce Astra-Zeneca vaccines locally

| @indiablooms | Apr 03, 2021, at 09:39 pm

The Bangladeshi government has sent a proposal to the pharmaceutical firm, AstraZeneca, to authorize it to produce its vaccine locally in Bangladesh, reported Daily Star. The country’s health minister said  the country has the capacity to produce it locally.

Zahid Maleques, the health minister of Bangladesh, speaking to the Daily Star, said, “We have sent a letter to AstraZeneca 10 days ago, requesting them to provide us their technology so that we can produce the vaccine locally and we have that capacity.”

However, the government is yet to receive a reply from the company.

Maleque also informed that government officials had visited the plants of some of the pharmaceutical firms in the country, and found them capable of producing the vaccine locally.

The main advantage of the AstraZeneca vaccine is that it can be restored at a relatively high temperature in comparison to other vaccines like BioNtech-Pfizer and Moderna.

Experts in the field hailed the government initiative and said it would greatly help the vaccination drive in the country if the company accepts the government request.

“What we need is the transfer of appropriate technology as most of the vaccines developed against Covid-19 have applied relatively newer techniques,” Md Sayedur Rahman, chairman of the pharmacology department at BSMMU, was quoted as saying by the Daily Star.

However, some experts also said the country’s drug authority, the Directorate General of Drug Administration (DGDA), needs to upgrade its labs to match the global standards.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.